Clinical Trial Update: Nabilone for Agitation Blinded Intervention Trial [Phase 3]

View source ↗

Summary

Phase 3 blinded trial of nabilone for agitation in Alzheimer disease is currently recruiting at Sunnybrook Health Sciences Centre.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Nabilone (nabilone)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Alzheimer Disease, Agitation | Phase 3 | Status: RECRUITING